US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Sagimet Biosciences Inc.

10.99

+0.49004.67%

Pre-market: 11.200.2100+1.91%04:23 EDT

Volume:1.80M

Turnover:19.56M

Market Cap:683.12M

PE:-8.80

High:11.06

Open:10.51

Low:10.51

Close:10.50

52wk High:11.15

52wk Low:4.50

Shares:62.16M

Float Shares:55.78M

Volume Ratio:2.30

T/O Rate:3.23%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.2490

EPS(LYR):-1.5800

ROE:-24.37%

ROA:-16.41%

PB:2.67

PE(LYR):-6.96

Loading ...

Overview Company News Filings

Sagimet Biosciences Inc - Plans Phase 3 Trial of Denifanstat in U.S. Acne Patients in H2 2026

THOMSON REUTERS

Sagimet Biosciences Provides Strategic and Corporate Updates

Sagimet Biosciences announces annual shareholder meeting notice

Sagimet Biosciences Appoints Andreas Grauer as Chief Medical Officer

Sagimet names Andreas Grauer chief medical officer as Eduardo Martins retires

Press Release: Sagimet Biosciences Announces Appointment of Andreas Grauer, MD, as Chief Medical Officer

Sagimet grants 9,600 inducement stock options to new hire under Nasdaq rule exception

Sagimet Biosciences Announces Poster and Oral Presentations at the Fueling MASH: Metabolic Drivers and Inflammatory Crosstalk Keystone Symposium and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Sagimet Biosciences initiated with a Buy at Rodman & Renshaw

Analysts Offer Insights on Healthcare Companies: Korro Bio (KRRO), Sagimet Biosciences, Inc. Class A (SGMT) and Bristol-Myers Squibb (BMY)

Sagimet Biosciences Inc reports results for the quarter ended December 31 - Earnings Summary

Sagimet Biosciences Price Target Maintained With a $29.00/Share by HC Wainwright & Co.

Sagimet: Undervalued MASH and Acne Pipeline with Best-in-Class Combination Potential Supports Buy Rating

Sagimet Biosciences Reports 2025 Results, Highlights Clinical Progress

Sagimet Biosciences Q4 net loss narrows as R&D expenses fall

Sagimet Biosciences Q4 EPS $(0.29) Beats $(0.48) Estimate

Benzinga Earnings

Sagimet Biosciences Q4 net loss narrows 41% to USD 9.57 million, cash falls 29% to USD 113.12 million

Sagimet Biosciences Q4 EPS USD -0.29

THOMSON REUTERS

Press Release: Sagimet Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Updates

Sagimet Biosciences Inc expected to post a loss of 41 cents a share - Earnings Preview

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/SGMT/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SGMT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SGMT\",,,,,undefined,":{"symbol":"SGMT","market":"US","secType":"STK","nameCN":"Sagimet Biosciences Inc.","latestPrice":10.99,"timestamp":1788379200000,"preClose":10.5,"halted":0,"volume":1801033,"hourTrading":{"tag":"盘前","latestPrice":11.2,"preClose":10.99,"latestTime":"04:23 EDT","volume":4,"amount":44.8,"timestamp":1788423834959,"change":0.21,"changeRate":0.019108,"amplitude":0},"delay":0,"changeRate":0.04666666666666669,"floatShares":55780800,"shares":62158653,"eps":-1.248952,"marketStatus":"Pre-Mkt","change":0.49,"latestTime":"09-03 05:13:01 EDT","open":10.51,"high":11.06,"low":10.51,"amount":19564376.538512,"amplitude":0.052381,"askPrice":12.54,"askSize":100,"bidPrice":10.06,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.248952,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788442200000},"marketStatusCode":1,"adr":0,"listingDate":1689307200000,"exchange":"NASDAQ","adjPreClose":10.99,"preHourTrading":{"tag":"盘前","latestPrice":11.2,"preClose":10.99,"latestTime":"04:23 EDT","volume":4,"amount":44.8,"timestamp":1788423834959,"change":0.21,"changeRate":0.019108,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":11.2493,"preClose":10.99,"latestTime":"19:57 EDT","volume":19003,"amount":211772.896,"timestamp":1788393426412,"change":0.2593,"changeRate":0.023594,"amplitude":0.028207},"volumeRatio":2.3032362349880344,"impliedVol":0.8463,"impliedVolPercentile":0.1394},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SGMT\",,,,,undefined,":{"symbol":"SGMT","floatShares":55780800,"roa":"-16.41%","roe":"-24.37%","lyrEps":-1.58,"volumeRatio":2.3032362349880344,"shares":62158653,"dividePrice":0,"high":11.06,"amplitude":0.052381,"preClose":10.5,"low":10.51,"week52Low":4.5,"pbRate":"2.67","week52High":11.15,"institutionHeld":0,"latestPrice":10.99,"eps":-1.248952,"divideRate":0,"volume":1801033,"delay":0,"ttmEps":-1.248952,"open":10.51,"prevYearClose":5.92,"prevWeekClose":10.55,"prevMonthClose":10.26,"prevQuarterClose":7.73,"fiveDayClose":10.86,"twentyDayClose":8.64,"sixtyDayClose":6.53},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SGMT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-11","symbol":"SGMT","fiscalQuarterEnding":"2026/06","expectedEps":-0.28,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786420800000,"reportTimeType":"pre","actualEps":-0.26},{"market":"US","date":"2026-05-12","symbol":"SGMT","fiscalQuarterEnding":"2026/03","expectedEps":-0.39,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"pre","actualEps":-0.33},{"market":"US","date":"2026-03-11","symbol":"SGMT","fiscalQuarterEnding":"2025/12","expectedEps":-0.43,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1773201600000,"reportTimeType":"pre","actualEps":-0.29},{"market":"US","date":"2025-11-13","symbol":"SGMT","fiscalQuarterEnding":"2025/09","expectedEps":-0.41,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"pre","actualEps":-0.4},{"market":"US","date":"2025-08-13","symbol":"SGMT","fiscalQuarterEnding":"2025/06","expectedEps":-0.52,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"pre","actualEps":-0.32}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SGMT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SGMT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.5833,"hold":0.0833,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5833,"analysts":12,"updateTime":1770177600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SGMT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SGMT","date":"2026-09-01","current":-8.799377,"percent":0.014455,"low":-15.666506,"twenty":-7.983451,"median":-4.357031,"eighty":-3.257919,"high":-1.342444,"avg":-5.456926,"sd":3.0117,"marketCap":637747779},"quantilePoints":[{"date":"2023-07-21","current":-12.287206,"twenty":-13.337015,"median":-12.553129,"eighty":-11.625533,"marketCap":348354576},{"date":"2023-07-28","current":-12.208993,"twenty":-12.714826,"median":-12.49838,"eighty":-12.113574,"marketCap":346137170},{"date":"2023-08-04","current":-12.733018,"twenty":-12.595364,"median":-12.529665,"eighty":-12.271563,"marketCap":360993794},{"date":"2023-08-11","current":-12.514023,"twenty":-12.565643,"median":-12.517933,"eighty":-12.42486,"marketCap":354785056},{"date":"2023-08-18","current":-9.925184,"twenty":-12.565643,"median":-12.514023,"eighty":-12.265307,"marketCap":281388897},{"date":"2023-08-25","current":-9.359416,"twenty":-12.554693,"median":-12.471006,"eighty":-10.020915,"marketCap":262381858},{"date":"2023-09-01","current":-9.85717,"twenty":-12.553129,"median":-12.459274,"eighty":-9.809842,"marketCap":276335907},{"date":"2023-09-08","current":-10.126447,"twenty":-12.543743,"median":-12.279385,"eighty":-9.775571,"marketCap":283884818},{"date":"2023-09-15","current":-9.791891,"twenty":-12.532793,"median":-11.532454,"eighty":-9.775571,"marketCap":274505868},{"date":"2023-09-22","current":-8.282308,"twenty":-12.524972,"median":-10.126447,"eighty":-9.674388,"marketCap":232186213},{"date":"2023-09-29","current":-7.392878,"twenty":-12.517151,"median":-9.936056,"eighty":-9.403479,"marketCap":207251930},{"date":"2023-10-06","current":-5.866975,"twenty":-12.514023,"median":-9.90613,"eighty":-8.80291,"marketCap":164474765},{"date":"2023-10-13","current":-4.757227,"twenty":-12.495252,"median":-9.80821,"eighty":-7.764969,"marketCap":133364100},{"date":"2023-10-20","current":-3.729078,"twenty":-12.478045,"median":-9.791891,"eighty":-6.978354,"marketCap":104540984},{"date":"2023-10-27","current":-3.647479,"twenty":-12.474916,"median":-9.751091,"eighty":-6.462648,"marketCap":102253435},{"date":"2023-11-03","current":-3.100765,"twenty":-12.467095,"median":-9.681732,"eighty":-5.866975,"marketCap":86926858},{"date":"2023-11-10","current":-2.284775,"twenty":-12.467095,"median":-9.514454,"eighty":-4.757227,"marketCap":64051369},{"date":"2023-11-17","current":-1.981702,"twenty":-12.459274,"median":-9.396135,"eighty":-4.030995,"marketCap":53347428},{"date":"2023-11-24","current":-3.487116,"twenty":-12.32162,"median":-9.116089,"eighty":-3.455541,"marketCap":93873157},{"date":"2023-12-01","current":-3.248971,"twenty":-12.280949,"median":-8.665823,"eighty":-3.326797,"marketCap":87462307},{"date":"2023-12-08","current":-3.436085,"twenty":-12.223071,"median":-7.870232,"eighty":-3.326797,"marketCap":92499403},{"date":"2023-12-15","current":-4.74588,"twenty":-11.827315,"median":-7.466317,"eighty":-3.305106,"marketCap":127759077},{"date":"2023-12-22","current":-4.79691,"twenty":-11.412789,"median":-6.927763,"eighty":-3.326797,"marketCap":129132830},{"date":"2023-12-29","current":-5.009539,"twenty":-10.856914,"median":-6.462648,"eighty":-3.351567,"marketCap":134856803},{"date":"2024-01-05","current":-4.286601,"twenty":-10.142767,"median":-6.27497,"eighty":-3.385054,"marketCap":115395295},{"date":"2024-01-12","current":-6.055674,"twenty":-10.126447,"median":-6.038333,"eighty":-3.402064,"marketCap":163018751},{"date":"2024-01-19","current":-5.494334,"twenty":-10.061168,"median":-5.928097,"eighty":-3.422477,"marketCap":147907462},{"date":"2024-01-26","current":-11.924235,"twenty":-11.412789,"median":-6.047003,"eighty":-3.434384,"marketCap":321000405},{"date":"2024-02-02","current":-11.8484,"twenty":-11.755197,"median":-6.332089,"eighty":-3.449693,"marketCap":318958920},{"date":"2024-02-09","current":-7.10904,"twenty":-11.755197,"median":-6.72671,"eighty":-3.480312,"marketCap":191375352},{"date":"2024-02-16","current":-10.260714,"twenty":-11.412789,"median":-7.18072,"eighty":-3.487116,"marketCap":276218424},{"date":"2024-02-23","current":-7.973973,"twenty":-11.272575,"median":-7.393401,"eighty":-3.512632,"marketCap":214659353},{"date":"2024-03-01","current":-7.263069,"twenty":-10.976358,"median":-7.495026,"eighty":-3.600344,"marketCap":195521817},{"date":"2024-03-08","current":-7.642218,"twenty":-10.478725,"median":-7.466317,"eighty":-3.696438,"marketCap":205728503},{"date":"2024-03-15","current":-5.118509,"twenty":-10.189946,"median":-7.39314,"eighty":-3.910228,"marketCap":137790253},{"date":"2024-03-22","current":-5.509506,"twenty":-10.132975,"median":-7.18072,"eighty":-4.056781,"marketCap":148315897},{"date":"2024-03-28","current":-6.56,"twenty":-10.093807,"median":-7.132737,"eighty":-4.084178,"marketCap":182866572},{"date":"2024-04-05","current":-6.239442,"twenty":-10.00568,"median":-6.795721,"eighty":-4.174333,"marketCap":173930684},{"date":"2024-04-12","current":-5.976126,"twenty":-9.938231,"median":-6.56,"eighty":-4.313817,"marketCap":166590490},{"date":"2024-04-19","current":-4.545061,"twenty":-9.925184,"median":-6.397368,"eighty":-4.392065,"marketCap":126698131},{"date":"2024-04-26","current":-4.487819,"twenty":-9.917562,"median":-6.217851,"eighty":-4.458405,"marketCap":125102437},{"date":"2024-05-03","current":-5.09459,"twenty":-9.886546,"median":-6.182199,"eighty":-4.468439,"marketCap":142016797},{"date":"2024-05-10","current":-5.231972,"twenty":-9.844114,"median":-6.079163,"eighty":-4.479356,"marketCap":145846463},{"date":"2024-05-17","current":-5.429865,"twenty":-9.811474,"median":-6.018678,"eighty":-4.487871,"marketCap":151590963},{"date":"2024-05-24","current":-5.372708,"twenty":-9.791891,"median":-5.987575,"eighty":-4.491214,"marketCap":149995268},{"date":"2024-05-31","current":-6.172899,"twenty":-9.791891,"median":-5.987575,"eighty":-4.501006,"marketCap":172334989},{"date":"2024-06-07","current":-5.315552,"twenty":-9.783731,"median":-5.976126,"eighty":-4.523122,"marketCap":148399574},{"date":"2024-06-14","current":-5.47559,"twenty":-9.751091,"median":-5.952111,"eighty":-4.533251,"marketCap":152867518},{"date":"2024-06-21","current":-4.446773,"twenty":-9.731508,"median":-5.91688,"eighty":-4.519544,"marketCap":124145020},{"date":"2024-06-28","current":-4.698262,"twenty":-9.718452,"median":-5.91688,"eighty":-4.523122,"marketCap":131166075},{"date":"2024-07-05","current":-3.257919,"twenty":-9.685812,"median":-5.888477,"eighty":-4.48795,"marketCap":90954577},{"date":"2024-07-12","current":-3.738033,"twenty":-9.677652,"median":-5.800519,"eighty":-4.448199,"marketCap":104358410},{"date":"2024-07-15","current":-3.806621,"twenty":-9.67602,"median":-5.796735,"eighty":-4.447058,"marketCap":106273243},{"date":"2024-08-02","current":-3.97809,"twenty":-9.674388,"median":-5.79295,"eighty":-4.391494,"marketCap":111060326},{"date":"2024-08-09","current":-3.109312,"twenty":-9.635837,"median":-5.632964,"eighty":-4.048186,"marketCap":86805772},{"date":"2024-08-16","current":-3.011259,"twenty":-9.556995,"median":-5.529634,"eighty":-3.765468,"marketCap":88082328},{"date":"2024-08-23","current":-3.174914,"twenty":-9.5049,"median":-5.509506,"eighty":-3.626007,"marketCap":92869411},{"date":"2024-08-30","current":-3.36039,"twenty":-9.480538,"median":-5.47559,"eighty":-3.517501,"marketCap":98294771},{"date":"2024-09-06","current":-2.913065,"twenty":-9.458966,"median":-5.429865,"eighty":-3.459899,"marketCap":85210078},{"date":"2024-09-13","current":-3.709522,"twenty":-9.418167,"median":-5.410329,"eighty":-3.440029,"marketCap":108507215},{"date":"2024-09-20","current":-3.578597,"twenty":-9.3382,"median":-5.372708,"eighty":-3.459899,"marketCap":104677549},{"date":"2024-09-27","current":-3.076721,"twenty":-9.217671,"median":-5.306102,"eighty":-3.426198,"marketCap":89997161},{"date":"2024-10-04","current":-4.495067,"twenty":-9.063099,"median":-5.281258,"eighty":-3.402458,"marketCap":131485214},{"date":"2024-10-11","current":-4.516888,"twenty":-9.008144,"median":-5.226248,"eighty":-3.408396,"marketCap":132123492},{"date":"2024-10-18","current":-5.891593,"twenty":-8.972181,"median":-5.273199,"eighty":-3.426198,"marketCap":172334989},{"date":"2024-10-25","current":-6.000697,"twenty":-8.935294,"median":-5.292689,"eighty":-3.429281,"marketCap":175526378},{"date":"2024-10-31","current":-5.826131,"twenty":-8.894301,"median":-5.311818,"eighty":-3.436085,"marketCap":170420156},{"date":"2024-11-08","current":-6.753511,"twenty":-8.791513,"median":-5.372708,"eighty":-3.436763,"marketCap":197546960},{"date":"2024-11-15","current":-5.651565,"twenty":-8.755967,"median":-5.41811,"eighty":-3.453095,"marketCap":165313934},{"date":"2024-11-22","current":-3.861691,"twenty":-8.665823,"median":-5.372708,"eighty":-3.487116,"marketCap":144879052},{"date":"2024-11-29","current":-4.882893,"twenty":-8.557843,"median":-5.315552,"eighty":-3.487116,"marketCap":183191513},{"date":"2024-12-06","current":-3.998995,"twenty":-8.332016,"median":-5.292689,"eighty":-3.504949,"marketCap":150030307},{"date":"2024-12-13","current":-3.896017,"twenty":-8.272608,"median":-5.273199,"eighty":-3.525595,"marketCap":146166866},{"date":"2024-12-20","current":-4.350838,"twenty":-8.042693,"median":-5.190447,"eighty":-3.550034,"marketCap":163230399},{"date":"2024-12-27","current":-4.35942,"twenty":-7.978712,"median":-5.107971,"eighty":-3.56885,"marketCap":163552352},{"date":"2025-01-03","current":-3.853109,"twenty":-7.96022,"median":-5.094591,"eighty":-3.578236,"marketCap":144557099},{"date":"2025-01-10","current":-4.608284,"twenty":-7.932249,"median":-5.088866,"eighty":-3.585335,"marketCap":172889002},{"date":"2025-01-17","current":-3.664315,"twenty":-7.891035,"median":-5.014451,"eighty":-3.578519,"marketCap":137474123},{"date":"2025-01-24","current":-3.561337,"twenty":-7.843641,"median":-5.001034,"eighty":-3.577995,"marketCap":133610681},{"date":"2025-01-31","current":-3.484103,"twenty":-7.800873,"median":-4.931489,"eighty":-3.565628,"marketCap":130713100},{"date":"2025-02-07","current":-4.041903,"twenty":-7.796247,"median":-4.899965,"eighty":-3.577995,"marketCap":151640074},{"date":"2025-02-14","current":-3.775875,"twenty":-7.711114,"median":-4.882893,"eighty":-3.5785,"marketCap":141659518},{"date":"2025-02-21","current":-3.454068,"twenty":-7.655997,"median":-4.848447,"eighty":-3.56477,"marketCap":129586263},{"date":"2025-02-28","current":-3.097934,"twenty":-7.585345,"median":-4.824006,"eighty":-3.534402,"marketCap":116225195},{"date":"2025-03-07","current":-3.13226,"twenty":-7.533213,"median":-4.786117,"eighty":-3.487116,"marketCap":117513009},{"date":"2025-03-14","current":-2.479989,"twenty":-7.4778,"median":-4.774032,"eighty":-3.471231,"marketCap":113005660},{"date":"2025-03-21","current":-2.861526,"twenty":-7.417463,"median":-4.751553,"eighty":-3.434384,"marketCap":130391147},{"date":"2025-03-28","current":-2.656626,"twenty":-7.395771,"median":-4.728869,"eighty":-3.400275,"marketCap":121054497},{"date":"2025-04-04","current":-1.603868,"twenty":-7.392983,"median":-4.702859,"eighty":-3.36039,"marketCap":73083433},{"date":"2025-04-11","current":-1.575606,"twenty":-7.289031,"median":-4.694849,"eighty":-3.31696,"marketCap":71795619},{"date":"2025-04-17","current":-1.42723,"twenty":-7.21366,"median":-4.648098,"eighty":-3.301626,"marketCap":65034596},{"date":"2025-04-25","current":-2.204435,"twenty":-7.173257,"median":-4.603993,"eighty":-3.254074,"marketCap":100449476},{"date":"2025-05-02","current":-2.77674,"twenty":-7.146955,"median":-4.575776,"eighty":-3.219588,"marketCap":126527705},{"date":"2025-05-09","current":-1.80385,"twenty":-7.118519,"median":-4.541885,"eighty":-3.18279,"marketCap":103025104},{"date":"2025-05-16","current":-1.865858,"twenty":-6.931314,"median":-4.533251,"eighty":-3.143037,"marketCap":106566591},{"date":"2025-05-23","current":-1.922228,"twenty":-6.7923,"median":-4.516125,"eighty":-3.120362,"marketCap":109786126},{"date":"2025-05-30","current":-1.972961,"twenty":-6.768572,"median":-4.505306,"eighty":-3.099066,"marketCap":112683707},{"date":"2025-06-06","current":-2.694501,"twenty":-6.722029,"median":-4.495067,"eighty":-3.076721,"marketCap":153893749},{"date":"2025-06-13","current":-4.853485,"twenty":-6.632098,"median":-4.487884,"eighty":-3.076721,"marketCap":277201920},{"date":"2025-06-20","current":-3.968471,"twenty":-6.566428,"median":-4.480766,"eighty":-3.076721,"marketCap":226655228},{"date":"2025-06-27","current":-4.904218,"twenty":-6.557243,"median":-4.495067,"eighty":-3.078851,"marketCap":280099501},{"date":"2025-07-03","current":-4.650551,"twenty":-6.546215,"median":-4.495067,"eighty":-3.087373,"marketCap":265611596},{"date":"2025-07-11","current":-5.586299,"twenty":-6.535304,"median":-4.505306,"eighty":-3.097934,"marketCap":319055868},{"date":"2025-07-18","current":-5.383366,"twenty":-6.492923,"median":-4.516888,"eighty":-3.100765,"marketCap":307465544},{"date":"2025-07-25","current":-5.749773,"twenty":-6.480752,"median":-4.529894,"eighty":-3.109312,"marketCap":328392519},{"date":"2025-08-01","current":-4.898581,"twenty":-6.480752,"median":-4.538709,"eighty":-3.120362,"marketCap":279777548},{"date":"2025-08-08","current":-5.101514,"twenty":-6.462648,"median":-4.566286,"eighty":-3.120362,"marketCap":291367872},{"date":"2025-08-15","current":-5.891315,"twenty":-6.437111,"median":-4.599703,"eighty":-3.13226,"marketCap":349838046},{"date":"2025-08-22","current":-4.025357,"twenty":-6.382559,"median":-4.566286,"eighty":-3.13419,"marketCap":239033752},{"date":"2025-08-29","current":-4.140367,"twenty":-6.360738,"median":-4.538709,"eighty":-3.140842,"marketCap":245863288},{"date":"2025-09-05","current":-3.97059,"twenty":-6.343282,"median":-4.533251,"eighty":-3.141915,"marketCap":235781592},{"date":"2025-09-12","current":-3.85558,"twenty":-6.333455,"median":-4.518739,"eighty":-3.143321,"marketCap":228952056},{"date":"2025-09-19","current":-3.696756,"twenty":-6.268752,"median":-4.505306,"eighty":-3.155125,"marketCap":219520793},{"date":"2025-09-26","current":-3.910347,"twenty":-6.242137,"median":-4.495589,"eighty":-3.161438,"marketCap":232204216},{"date":"2025-10-03","current":-3.9213,"twenty":-6.222169,"median":-4.487819,"eighty":-3.17239,"marketCap":232854648},{"date":"2025-10-10","current":-4.720895,"twenty":-6.216806,"median":-4.469318,"eighty":-3.185415,"marketCap":280336183},{"date":"2025-10-17","current":-4.134891,"twenty":-6.207386,"median":-4.448199,"eighty":-3.194996,"marketCap":245538072},{"date":"2025-10-24","current":-4.014404,"twenty":-6.179338,"median":-4.440945,"eighty":-3.205463,"marketCap":238383320},{"date":"2025-10-31","current":-4.458014,"twenty":-6.166061,"median":-4.448199,"eighty":-3.212557,"marketCap":264725815},{"date":"2025-11-07","current":-4.211564,"twenty":-6.160312,"median":-4.446004,"eighty":-3.221522,"marketCap":250091096},{"date":"2025-11-14","current":-4.238947,"twenty":-6.115309,"median":-4.446773,"eighty":-3.228264,"marketCap":251717176},{"date":"2025-11-21","current":-4.099669,"twenty":-6.104311,"median":-4.436499,"eighty":-3.233938,"marketCap":236432024},{"date":"2025-11-28","current":-4.071473,"twenty":-6.101058,"median":-4.420471,"eighty":-3.243405,"marketCap":234805944},{"date":"2025-12-05","current":-3.580867,"twenty":-6.095284,"median":-4.404184,"eighty":-3.254074,"marketCap":206512153},{"date":"2025-12-12","current":-3.569588,"twenty":-6.08465,"median":-4.372292,"eighty":-3.257742,"marketCap":205861721},{"date":"2025-12-19","current":-3.360939,"twenty":-6.079163,"median":-4.354642,"eighty":-3.257919,"marketCap":193828730},{"date":"2025-12-26","current":-3.417331,"twenty":-6.078325,"median":-4.333675,"eighty":-3.272875,"marketCap":197080889},{"date":"2026-01-02","current":-3.338383,"twenty":-6.07279,"median":-4.295418,"eighty":-3.296029,"marketCap":192527866},{"date":"2026-01-09","current":-3.141012,"twenty":-6.052206,"median":-4.275812,"eighty":-3.257565,"marketCap":181145306},{"date":"2026-01-16","current":-3.530114,"twenty":-6.030806,"median":-4.260854,"eighty":-3.257919,"marketCap":203585209},{"date":"2026-01-23","current":-3.580867,"twenty":-6.000697,"median":-4.24786,"eighty":-3.257919,"marketCap":206512153},{"date":"2026-01-30","current":-3.02259,"twenty":-5.999023,"median":-4.239278,"eighty":-3.257919,"marketCap":174315770},{"date":"2026-02-06","current":-3.067703,"twenty":-5.987575,"median":-4.238947,"eighty":-3.257919,"marketCap":176917498},{"date":"2026-02-13","current":-2.904167,"twenty":-5.987575,"median":-4.207457,"eighty":-3.229466,"marketCap":167486234},{"date":"2026-02-20","current":-3.033868,"twenty":-5.978416,"median":-4.198491,"eighty":-3.205597,"marketCap":174966202},{"date":"2026-02-27","current":-3.310187,"twenty":-5.976126,"median":-4.171404,"eighty":-3.19727,"marketCap":190901786},{"date":"2026-03-06","current":-3.073342,"twenty":-5.960869,"median":-4.151321,"eighty":-3.194996,"marketCap":177242714},{"date":"2026-03-13","current":-3.409312,"twenty":-5.933889,"median":-4.134891,"eighty":-3.179372,"marketCap":174004471},{"date":"2026-03-20","current":-3.083704,"twenty":-5.922747,"median":-4.112984,"eighty":-3.173773,"marketCap":157386066},{"date":"2026-03-27","current":-3.262469,"twenty":-5.915013,"median":-4.099669,"eighty":-3.155125,"marketCap":166509896},{"date":"2026-04-02","current":-3.345467,"twenty":-5.912776,"median":-4.084811,"eighty":-3.143037,"marketCap":170745960},{"date":"2026-04-10","current":-3.600846,"twenty":-5.910928,"median":-4.072723,"eighty":-3.152245,"marketCap":183780003},{"date":"2026-04-17","current":-3.951993,"twenty":-5.905493,"median":-4.058653,"eighty":-3.16058,"marketCap":201701812},{"date":"2026-04-24","current":-3.74769,"twenty":-5.895957,"median":-4.054569,"eighty":-3.166443,"marketCap":191274578},{"date":"2026-05-01","current":-9.715643,"twenty":-5.895957,"median":-4.071473,"eighty":-3.172632,"marketCap":495867010},{"date":"2026-05-08","current":-9.243775,"twenty":-5.916612,"median":-4.077048,"eighty":-3.178257,"marketCap":471783805},{"date":"2026-05-15","current":-10.459432,"twenty":-5.976126,"median":-4.099487,"eighty":-3.185018,"marketCap":455110817},{"date":"2026-05-22","current":-9.934332,"twenty":-5.999693,"median":-4.106949,"eighty":-3.193257,"marketCap":432262649},{"date":"2026-05-29","current":-10.317513,"twenty":-6.068511,"median":-4.112984,"eighty":-3.197003,"marketCap":448935636},{"date":"2026-06-05","current":-10.019483,"twenty":-6.096486,"median":-4.130758,"eighty":-3.2015,"marketCap":435967757},{"date":"2026-06-12","current":-9.125393,"twenty":-6.162332,"median":-4.137629,"eighty":-3.210101,"marketCap":397064119},{"date":"2026-06-18","current":-9.267312,"twenty":-6.214255,"median":-4.165012,"eighty":-3.21502,"marketCap":403239299},{"date":"2026-06-26","current":-9.735645,"twenty":-6.316255,"median":-4.173227,"eighty":-3.220659,"marketCap":423617396},{"date":"2026-07-02","current":-10.587159,"twenty":-6.382559,"median":-4.200611,"eighty":-3.223456,"marketCap":460668480},{"date":"2026-07-10","current":-10.431048,"twenty":-6.480752,"median":-4.221131,"eighty":-3.225599,"marketCap":453875781},{"date":"2026-07-17","current":-10.856806,"twenty":-6.56,"median":-4.239278,"eighty":-3.229466,"marketCap":472401323},{"date":"2026-07-24","current":-9.948524,"twenty":-6.778613,"median":-4.241851,"eighty":-3.235056,"marketCap":432880167},{"date":"2026-07-31","current":-10.374281,"twenty":-7.139846,"median":-4.251619,"eighty":-3.241664,"marketCap":451405709},{"date":"2026-08-07","current":-12.403723,"twenty":-7.392983,"median":-4.260854,"eighty":-3.247188,"marketCap":539710793},{"date":"2026-08-14","current":-12.252433,"twenty":-7.533213,"median":-4.28742,"eighty":-3.248808,"marketCap":576832299},{"date":"2026-08-21","current":-13.440708,"twenty":-7.797172,"median":-4.325957,"eighty":-3.255775,"marketCap":632775087},{"date":"2026-08-28","current":-14.193282,"twenty":-7.946467,"median":-4.35274,"eighty":-3.25783,"marketCap":668205519},{"date":"2026-09-01","current":-13.546332,"twenty":-7.983451,"median":-4.357031,"eighty":-3.257919,"marketCap":637747779}],"updateTime":1788406670855},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SGMT\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2630989453","title":"Sagimet Biosciences Inc - Plans Phase 3 Trial of Denifanstat in U.S. Acne Patients in H2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2630989453","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630989453?lang=en_us&edition=fundamental","pubTime":"2026-04-27 19:00","pubTimestamp":1777287603,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nTUA6XFJTY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SGMT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630393354","title":"Sagimet Biosciences Provides Strategic and Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2630393354","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630393354?lang=en_us&edition=fundamental","pubTime":"2026-04-27 19:00","pubTimestamp":1777287600,"startTime":"0","endTime":"0","summary":"Phase 3 clinical trial of denifanstat in moderate to severe acne patients for the U.S.planned to initiate in second half of 2026 First-in-human Phase 1 clinical trial of FASN inhibitor TVB-3567 ongoin","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/27/3281481/0/en/Sagimet-Biosciences-Provides-Strategic-and-Corporate-Updates.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGMT","00511","BK4139","IND","BK1145"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629841050","title":"Sagimet Biosciences announces annual shareholder meeting notice","url":"https://stock-news.laohu8.com/highlight/detail?id=2629841050","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629841050?lang=en_us&edition=fundamental","pubTime":"2026-04-22 04:13","pubTimestamp":1776802401,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences schedules virtual annual stockholder meeting for June 12, 2026.Shareholders will vote on election of four Class III directors for terms expiring in 2029.Ballot also includes ratification of KPMG as independent registered public accounting firm for fiscal 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sagimet Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 21, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nNDL5gFpbC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SGMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629756080","title":"Sagimet Biosciences Appoints Andreas Grauer as Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2629756080","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629756080?lang=en_us&edition=fundamental","pubTime":"2026-04-21 18:38","pubTimestamp":1776767887,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences, Inc. Class A ( ($SGMT) ) just unveiled an announcement. On April 20, 2026, Sagimet Biosciences, Inc. Class A appointed Andreas...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sagimet-biosciences-appoints-andreas-grauer-as-chief-medical-officer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sagimet-biosciences-appoints-andreas-grauer-as-chief-medical-officer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4535","BK4139","BK4588","BK4568","BNTX","BK4548","SGMT","BK4551","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628174259","title":"Sagimet names Andreas Grauer chief medical officer as Eduardo Martins retires","url":"https://stock-news.laohu8.com/highlight/detail?id=2628174259","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628174259?lang=en_us&edition=fundamental","pubTime":"2026-04-20 19:01","pubTimestamp":1776682896,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences appointed Andreas Grauer as chief medical officer, effective April 20, 2026.Grauer most recently served as chief medical officer at Omeros, leading clinical, safety, and medical functions for complement-targeted therapies.Martins will continue to support Sagimet as an external scientific advisor.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sagimet Biosciences Inc. published the original content used to generate this news brief on April 20, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nNDL3YnvGb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGMT","BK4139","OMER","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628373742","title":"Press Release: Sagimet Biosciences Announces Appointment of Andreas Grauer, MD, as Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2628373742","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628373742?lang=en_us&edition=fundamental","pubTime":"2026-04-20 19:00","pubTimestamp":1776682800,"startTime":"0","endTime":"0","summary":"SAN MATEO, Calif., April 20, 2026  -- Sagimet Biosciences Inc. , a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced the appointment of Andreas Grauer, MD, as Chief Medical Officer, effective April 20, 2026. Sagimet's prior Chief Medical Officer, Eduardo Bruno Martins, MD, DPhil, who will continue to support the Company as an external scientific advisor, has retired effective April 20, 2026.\"We are delighted to welcome Dr. Andreas Grauer to our executive leadership team as Chief Medical Officer. Dr. Grauer has an extensive track record in leading clinical development and medical affairs in global pharmaceutical organizations as well as an impressive academic career. His expertise and insights will be key as we advance our FASN inhibitors in clinical development,\" said David Happel, Chief Executive Officer of Sagimet. \"We also want to thank Dr. Eduardo Martins for his many significant contribut","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BK4568","BNTX","BK4585","BK4139","BK4535","BK4007","MD","SGMT","BK4588","BK4551","BK4548","OMER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625676834","title":"Sagimet grants 9,600 inducement stock options to new hire under Nasdaq rule exception","url":"https://stock-news.laohu8.com/highlight/detail?id=2625676834","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625676834?lang=en_us&edition=fundamental","pubTime":"2026-04-06 19:00","pubTimestamp":1775473220,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences granted stock options covering 9,600 shares to a newly hired employee on April 3, 2026.Award vests over four years, with 25% vesting after one year.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260406:nNDLc0TRj9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","IE00B3QW5Z07.USD","SG9999014021.USD","BK4588","LU2095319765.USD","SG9999014013.SGD","IE00BKPKM429.USD","BK4585","LU0314104364.USD","SG9999014039.USD","IE00BN0W2V16.EUR","IE00BGHQF748.EUR","IE00BN0W2W23.USD","LU2210150020.SGD","IE00BN0W2T93.GBP","SGMT","IE00B64PRP62.GBP","LU2210149790.SGD","BK4139","SG9999014005.SGD","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625763476","title":"Sagimet Biosciences Announces Poster and Oral Presentations at the Fueling MASH: Metabolic Drivers and Inflammatory Crosstalk Keystone Symposium and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2625763476","media":"GlobeNewswire","labels":["shareholding","conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625763476?lang=en_us&edition=fundamental","pubTime":"2026-04-06 19:00","pubTimestamp":1775473200,"startTime":"0","endTime":"0","summary":"SAN MATEO, Calif., April  06, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabol","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/06/3268332/0/en/Sagimet-Biosciences-Announces-Poster-and-Oral-Presentations-at-the-Fueling-MASH-Metabolic-Drivers-and-Inflammatory-Crosstalk-Keystone-Symposium-and-Inducement-Grant-Under-Nasdaq-Li.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SGMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622852299","title":"Sagimet Biosciences initiated with a Buy at Rodman & Renshaw","url":"https://stock-news.laohu8.com/highlight/detail?id=2622852299","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622852299?lang=en_us&edition=fundamental","pubTime":"2026-03-26 19:46","pubTimestamp":1774525586,"startTime":"0","endTime":"0","summary":"Rodman & Renshaw initiated coverage of Sagimet Biosciences (SGMT) with a Buy rating and $28 price target Published first on TheFly – the ultimate s...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sagimet-biosciences-initiated-with-a-buy-at-rodman-renshaw-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sagimet-biosciences-initiated-with-a-buy-at-rodman-renshaw-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","SGMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619193646","title":"Analysts Offer Insights on Healthcare Companies: Korro Bio (KRRO), Sagimet Biosciences, Inc. Class A (SGMT) and Bristol-Myers Squibb (BMY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2619193646","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619193646?lang=en_us&edition=fundamental","pubTime":"2026-03-13 17:50","pubTimestamp":1773395409,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Korro Bio (KRRO – Research Report), Sagimet Biosci...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-korro-bio-krro-sagimet-biosciences-inc-class-a-sgmt-and-bristol-myers-squibb-bmy-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-korro-bio-krro-sagimet-biosciences-inc-class-a-sgmt-and-bristol-myers-squibb-bmy-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0882574055.USD","BMY","LU1989771016.USD","LU1868837136.USD","LU1074936037.SGD","LU2133065610.SGD","LU0128526141.USD","XBI","LU1585245621.USD","BK4588","LU1883839398.USD","LU0237698245.USD","IE00BJJMRZ35.SGD","LU1323610961.USD","IE00B2B36J28.USD","LU0456855351.SGD","LU1571399168.USD","LU1670710661.SGD","LU1868836757.USD","LU1718418525.SGD","LU1093756325.SGD","LU2360032135.SGD","SGMT","LU0306806265.USD","LU1093756168.USD","LU1291159041.SGD","LU1868836591.USD","LU0225284248.USD","XLV","LU0096364046.USD","LU2242652126.USD","LU1032466523.USD","BK4585","LU0061475181.USD","LU1670711123.USD","LU0868494617.USD","BK4559","KRRO","LU1430594728.SGD","LU0306807586.USD","IE0009355771.USD","BK4007","HCSG","BK4581","IE00BFXG1179.USD","LU0321505439.SGD","LU1868836914.USD","BK4137","LABU","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618372541","title":"Sagimet Biosciences Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2618372541","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618372541?lang=en_us&edition=fundamental","pubTime":"2026-03-12 21:31","pubTimestamp":1773322272,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences Inc reports results for the quarter ended December 31 - Earnings SummarySagimet Biosciences Inc SGMT.OQ reported a quarterly adjusted loss of 29 cents per share for the quarter end","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nL8N4001NQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGMT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618279922","title":"Sagimet Biosciences Price Target Maintained With a $29.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2618279922","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618279922?lang=en_us&edition=fundamental","pubTime":"2026-03-12 01:38","pubTimestamp":1773250680,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SGMT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 11, 2026 13:38 ET (17:38 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618929895","title":"Sagimet: Undervalued MASH and Acne Pipeline with Best-in-Class Combination Potential Supports Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2618929895","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618929895?lang=en_us&edition=fundamental","pubTime":"2026-03-11 23:15","pubTimestamp":1773242133,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences, Inc. Class A, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Brandon Folkes from H.C. Wa...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/sagimet-undervalued-mash-and-acne-pipeline-with-best-in-class-combination-potential-supports-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/sagimet-undervalued-mash-and-acne-pipeline-with-best-in-class-combination-potential-supports-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4581","LABU","BK4588","BK4585","XLV","SGMT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618299944","title":"Sagimet Biosciences Reports 2025 Results, Highlights Clinical Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2618299944","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618299944?lang=en_us&edition=fundamental","pubTime":"2026-03-11 19:59","pubTimestamp":1773230348,"startTime":"0","endTime":"0","summary":"An update from Sagimet Biosciences, Inc. Class A ( ($SGMT) ) is now available. Sagimet Biosciences reported its fourth-quarter and full-year 2025 r...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sagimet-biosciences-reports-2025-results-highlights-clinical-progress?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sagimet-biosciences-reports-2025-results-highlights-clinical-progress?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065732104.USD","SGMT","PRGS","BK4097","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618941265","title":"Sagimet Biosciences Q4 net loss narrows as R&D expenses fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2618941265","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618941265?lang=en_us&edition=fundamental","pubTime":"2026-03-11 19:39","pubTimestamp":1773229167,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences Q4 net loss narrows as R&D expenses fallOverviewU.S. biopharma firm's Q4 net loss narrowed yr/yrQ4 research and development expense declined from prior yearCompany completed Phase ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nL1N3ZZ0JR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGMT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618412839","title":"Sagimet Biosciences Q4 EPS $(0.29) Beats $(0.48) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2618412839","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618412839?lang=en_us&edition=fundamental","pubTime":"2026-03-11 19:36","pubTimestamp":1773228970,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences (NASDAQ:SGMT) reported quarterly losses of $(0.29) per share which beat the analyst consensus estimate of $(0.48) by 39.08 percent. This is a 42 percent increase over losses of $(0.50) per share from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/03/51182417/sagimet-biosciences-q4-eps-0-29-beats-0-48-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618941117","title":"Sagimet Biosciences Q4 net loss narrows 41% to USD 9.57 million, cash falls 29% to USD 113.12 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2618941117","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618941117?lang=en_us&edition=fundamental","pubTime":"2026-03-11 19:31","pubTimestamp":1773228684,"startTime":"0","endTime":"0","summary":"Sagimet reported a Q4 net loss of USD 9.57 million, narrowing 41% from the prior-year period. Q4 R&D expense was USD 6.73 million, down 53%. For FY 2025, net loss was USD 51.04 million, widening 12%, while R&D expense was USD 39.05 million. Cash, cash equivalents and marketable securities totaled USD 113.12 million at year-end, down 29%. The company said it completed a Phase 1 pharmacokinetic trial of denifanstat in combination with resmetirom and plans to initiate a Phase 2 proof-of-concept trial in F4 MASH in 2H 2026, and it is running a first-in-human Phase 1 trial of FASN inhibitor TVB-3567.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nNDLblFtcD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","LU2095319765.USD","LU2210149790.SGD","SGMT","IE00B64PRP62.GBP","IE00BGHQF748.EUR","LU0314104364.USD","BK4585","SG9999014021.USD","SG9999014039.USD","BK4588","IE00B3QW5Z07.USD","LU2210150020.SGD","SG9999014005.SGD","NDAQ","BK4139","SG9999014013.SGD","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618455941","title":"Sagimet Biosciences Q4 EPS USD -0.29","url":"https://stock-news.laohu8.com/highlight/detail?id=2618455941","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618455941?lang=en_us&edition=fundamental","pubTime":"2026-03-11 19:30","pubTimestamp":1773228601,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nPLX931C0A:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SGMT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618941435","title":"Press Release: Sagimet Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2618941435","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618941435?lang=en_us&edition=fundamental","pubTime":"2026-03-11 19:30","pubTimestamp":1773228600,"startTime":"0","endTime":"0","summary":"Completed Phase 1 pharmacokinetic  clinical trial of denifanstat and resmetirom combination. Secured global, exclusive license to TAPI's innovative forms of resmetirom active pharmaceutical ingredients . First-in-human Phase 1 clinical trial of FASN inhibitor TVB-3567 ongoing. Positive topline results in open-label Phase 3 trial evaluating the long-term safety of denifanstat in patients with moderate to severe acne in China reported by Ascletis. \"2025 saw important advances in both our MASH and acne programs,\" said David Happel, Chief Executive Officer of Sagimet. \"We completed our Phase 1 PK clinical trial of denifanstat and resmetirom combination and anticipate advancing the combination into a proof-of-concept Phase 2 clinical trial in F4 MASH, for which there are currently no approved treatments, in the second half of the year. In acne, positive 52-week data from our license partner Ascletis' Phase 3 open-label acne trial with denifanstat will support Ascletis' NDA that was accepted","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PK","BK4023","BK4181","BK4139","BK1145","BK4232","BK4218","BK4022","BK4085","DDI","API","R","BK4503","00511","BK4551","BK4535","SGMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618587259","title":"Sagimet Biosciences Inc  expected to post a loss of 41 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2618587259","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618587259?lang=en_us&edition=fundamental","pubTime":"2026-03-10 20:53","pubTimestamp":1773147187,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences Inc  expected to post a loss of41cents a share - Earnings Preview Sagimet Biosciences Inc SGMT.OQ SGMT.O is expected to  show no change in quarterly revenue when it reports  result","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260310:nL8N3ZY1A6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGMT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":5,"totalSize":100,"code":"91000000","status":"200"}]}}